BDBM505759 (S)-1-(4-(benzo[d]thiazol-7-yl((8- bromo-3-cyano-4-(neopentylamino)- quinolin-6-yl)amino)methyl)-1H-1,2,3- triazol-1-yl)cyclopropane-1- carboxamide::US11066414, Compound 408

SMILES CC(C)(C)CNc1c(C#N)cnc2c(Br)cc(N[C@H](C3=CN(C4(C(N)=O)CC4)NN3)c3cccc4ncsc34)cc12

InChI Key InChIKey=YEICRWWOFRUDEO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 505759   

TargetEpidermal growth factor receptor(Human)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 505759BDBM505759((S)-1-(4-(benzo[d]thiazol-7-yl((8- bromo-3-cyano-4...)
Affinity DataIC50: 1nMAssay Description:EGFR activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, EGFR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2021
Entry Details
US Patent